[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)]

Geltrude Mingrone, Lorenzo Altomonte, Giovanni Ghirlanda, Raffaele Manna, Antonio Giuseppe Rebuzzi, Ma Pala, Av Greco

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The biliary lithogenous index before and after treatment with Etofibrate, a new hypolipaemizing substance, has been assessed in dyslipidaemic subjects (ypes II and IV). Etofibrate is the result of the association of a molecule of clofibrate and one of nicotinic acid. An analysis of relative molar concentrations of biliary lipides showed that subjects with type IV and IIb dyslipidaemia produced lithogenous bile in base condition, unlike subjects with type IIa dyslipidaemia. After 28 days of treatment with Etofibrate (900 mg/die) a clear-cut increase was observed in the biliary lithogenous index in all types of dyslipidaemia examined.
Titolo tradotto del contributo[Autom. eng. transl.] Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)
Lingua originaleItalian
pagine (da-a)273-278
Numero di pagine6
RivistaMinerva Medica
Volume71
Stato di pubblicazionePubblicato - 1980

Keywords

  • Adult
  • Aged
  • Bile
  • Clofibrate
  • Clofibric Acid
  • Female
  • Humans
  • Hyperlipoproteinemia Type II
  • Hyperlipoproteinemia Type IV
  • Hypolipidemic Agents
  • Lipids
  • Male
  • Middle Aged

Fingerprint

Entra nei temi di ricerca di '[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)]'. Insieme formano una fingerprint unica.

Cita questo